POSTED ON JANUARY 07, 2020 The Lewis Katz School of Medicine at Temple University (LKSOM) has received a gift from Temple University trustee, benefactor and Fox School of Business alumnus Phil Richards and the Scott Richards North Star Charitable Foundation (SRNSCF), as well as Stop Alzheimer’s Now (SAN), to establish the Scott Richards North Star Foundation and Stop Alzheimer’s Now Chair for Alzheimer’s Research at the Alzheimer’s Center at Temple. The gift to establish the Chair will be utilized exclusively for the purpose of funding Alzheimer’s research at the Alzheimer’s Center at Temple (ACT). The name of the researcher who will be first occupant of the new chair position will be announced at a later date. “We’re extremely thankful to the Scott Richards North Star Charitable Foundation and Stop Alzheimer’s Now for this generous gift,” said John M. Daly, MD, FACS, Interim Dean and Harry C. Donahoo Professor of Surgery at LKSOM. “That these two organizations would select Temple for this donation speaks volumes to the promising work being done by Dr. Domenico Praticò and his team at the Alzheimer’s Center at Temple. The Alzheimer’s Center is performing cutting-edge research into the causation, prevention and ultimately cure of this devastating disease.” The Scott Richards North Star Charitable Foundation is a Minnesota non-profit corporation, and Stop Alzheimer’s Now is a Texas non-profit corporation. Both have a core funding priority of ending Alzheimer’s disease. In 2018 SRNSCF provided a gift to LKSOM to establish the Scott Richards North Star Charitable Foundation Chair for Alzheimer’s Research at Temple as well as the Alzheimer’s Center at Temple. Domenico Praticò, MD, was appointed the first Scott Richards North Star Charitable Foundation Chair for Alzheimer’s Research and Professor and Director of the Alzheimer’s Center at Temple. The occupant of the new chair funded by this latest gift will report to Dr. Praticò. SAN also provided a gift in early 2019 to fund research at ACT.
2 Comments
New Study at Temple Shows Extra Virgin Olive Oil Staves Off Multiple Forms of Dementia in Mice11/27/2019 Boosting brain function is key to staving off the effects of aging. And if there was one thing every person should consider doing right now to keep their brain young, it is to add extra virgin olive oil (EVOO) to their diet, according to research by scientists at the Lewis Katz School of Medicine at Temple University (LKSOM). EVOO is a superfood, rich in cell-protecting antioxidants and known for its multiple health benefits, including helping put the brakes on diseases linked to aging, most notably cardiovascular disease. Previous LKSOM research on mice also showed that EVOO preserves memory and protects the brain against Alzheimer's disease
In a new study in mice published online in the journal Aging Cell, LKSOM scientists show that yet another group of aging-related diseases can be added to that list – tauopathies, which are characterized by the gradual buildup of an abnormal form of a protein called tau in the brain. This process leads to a decline in mental function, or dementia. The findings are the first to suggest that EVOO can defend against a specific type of mental decline linked to tauopathy known as frontotemporal dementia. The Next Leg of our Journey |